Epitomee Medical (Israel) Performance
| EPIT Stock | 889.90 29.30 3.19% |
The firm shows a Beta (market volatility) of 1.37, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Epitomee Medical will likely underperform. At this point, Epitomee Medical has a negative expected return of -0.34%. Please make sure to confirm Epitomee Medical's downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Epitomee Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Epitomee Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Epitomee |
Epitomee Medical Relative Risk vs. Return Landscape
If you would invest 114,800 in Epitomee Medical on October 23, 2024 and sell it today you would lose (22,880) from holding Epitomee Medical or give up 19.93% of portfolio value over 90 days. Epitomee Medical is generating negative expected returns and assumes 5.2218% volatility on return distribution over the 90 days horizon. Simply put, 46% of stocks are less volatile than Epitomee, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Epitomee Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Epitomee Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Epitomee Medical, and traders can use it to determine the average amount a Epitomee Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0645
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EPIT |
Estimated Market Risk
| 5.22 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.34 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Epitomee Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Epitomee Medical by adding Epitomee Medical to a well-diversified portfolio.
Epitomee Medical Fundamentals Growth
Epitomee Stock prices reflect investors' perceptions of the future prospects and financial health of Epitomee Medical, and Epitomee Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Epitomee Stock performance.
| Current Valuation | 339.18 M | |||
| Shares Outstanding | 29.58 M | |||
| Price To Book | 3.48 X | |||
About Epitomee Medical Performance
By analyzing Epitomee Medical's fundamental ratios, stakeholders can gain valuable insights into Epitomee Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Epitomee Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Epitomee Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Epitomee Medical performance evaluation
Checking the ongoing alerts about Epitomee Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Epitomee Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Epitomee Medical generated a negative expected return over the last 90 days | |
| Epitomee Medical has high historical volatility and very poor performance | |
| About 57.0% of the company shares are held by company insiders |
- Analyzing Epitomee Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Epitomee Medical's stock is overvalued or undervalued compared to its peers.
- Examining Epitomee Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Epitomee Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Epitomee Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Epitomee Medical's stock. These opinions can provide insight into Epitomee Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Epitomee Stock analysis
When running Epitomee Medical's price analysis, check to measure Epitomee Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epitomee Medical is operating at the current time. Most of Epitomee Medical's value examination focuses on studying past and present price action to predict the probability of Epitomee Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epitomee Medical's price. Additionally, you may evaluate how the addition of Epitomee Medical to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |